Cipher Pharmaceuticals Inc. (CPHRF)

Cipher Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	225	255	101	71	37	20
Market Cap Growth	152.73%	152.73%	41.37%	94.22%	86.01%	-36.77%
Enterprise Value	248	284	58	44	21	18
Last Close Price	8.80	9.97	4.19	2.79	1.41	0.72
PE Ratio	19.50	22.06	4.94	2.68	4.73	4.34
PS Ratio	7.63	7.63	4.76	3.45	1.67	0.91
PB Ratio	2.49	2.49	1.25	1.11	0.94	0.60
P/TBV Ratio	41.47	41.47	1.60	1.56	1.88	1.55
P/FCF Ratio	-	6.36	6.70	2.66	1.69
P/OCF Ratio	13.03	13.03	6.30	6.65	2.66	1.69
EV/Sales Ratio	7.39	8.51	2.74	2.12	0.96	0.85
EV/EBITDA Ratio	20.79	24.29	5.07	3.67	1.54	1.39
EV/EBIT Ratio	31.43	36.19	5.63	3.97	1.62	1.51
EV/FCF Ratio	-4.10	-	3.66	4.12	1.53	1.58
Debt / Equity Ratio	0.40	0.40	0.00	0.01	0.01	0.06
Debt / EBITDA Ratio	3.42	3.42	0.03	0.04	0.04	0.14
Debt / FCF Ratio	-	-	0.02	0.04	0.04	0.16
Asset Turnover	0.27	0.27	0.27	0.33	0.46	0.48
Inventory Turnover	2.11	2.11	1.59	2.10	2.90	3.16
Quick Ratio	1.60	1.60	8.55	3.80	2.21	1.85
Current Ratio	1.94	1.94	9.19	4.07	2.38	2.03
Return on Equity (ROE)	12.63%	12.63%	28.19%	51.73%	21.69%	14.46%
Return on Assets (ROA)	3.95%	3.95%	8.06%	11.01%	17.02%	16.76%
Return on Capital (ROIC)	4.38%	4.38%	8.86%	13.29%	22.09%	21.10%
Return on Capital Employed (ROCE)	5.50%	5.50%	12.80%	17.20%	33.20%	35.40%
Earnings Yield	5.13%	4.53%	20.23%	37.37%	21.14%	23.05%
FCF Yield	-26.87%	-23.75%	15.73%	14.93%	37.64%	59.20%
Buyback Yield / Dilution	0.79%	0.79%	1.46%	3.84%	1.96%	-1.52%

Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.